J Spiesser

438 total citations
14 papers, 263 citations indexed

About

J Spiesser is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, J Spiesser has authored 14 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in J Spiesser's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Acute Ischemic Stroke Management (3 papers) and Pharmaceutical Economics and Policy (2 papers). J Spiesser is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Acute Ischemic Stroke Management (3 papers) and Pharmaceutical Economics and Policy (2 papers). J Spiesser collaborates with scholars based in Australia, France and Sweden. J Spiesser's co-authors include Sylvie Gabriel, Patrizia Carità, Zalmaï Hakimi, Graeme J. Hankey, Stéphane Roze, Andrew Palmer, Morten Lammert, William J. Valentine, Peter Lindgren and Bengt Jönsson and has published in prestigious journals such as Journal of the American College of Cardiology, Neurology and Clinical Therapeutics.

In The Last Decade

J Spiesser

11 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Spiesser Australia 6 135 119 70 46 41 14 263
César Minelli Brazil 7 145 1.1× 72 0.6× 51 0.7× 50 1.1× 58 1.4× 13 246
David Leander Rimmele Germany 9 149 1.1× 88 0.7× 38 0.5× 68 1.5× 52 1.3× 30 274
Sven‐Erik Eriksson Sweden 6 287 2.1× 168 1.4× 71 1.0× 127 2.8× 93 2.3× 11 385
Kürşad Kutluk Türkiye 7 264 2.0× 218 1.8× 60 0.9× 64 1.4× 121 3.0× 23 476
A. Doris Baumgartner Switzerland 4 222 1.6× 115 1.0× 42 0.6× 107 2.3× 51 1.2× 4 309
Lai‐Kin Wong New Zealand 9 83 0.6× 86 0.7× 121 1.7× 34 0.7× 32 0.8× 14 218
David S Liebeskind United States 8 129 1.0× 61 0.5× 26 0.4× 84 1.8× 76 1.9× 22 280
Lucie Garnier France 10 232 1.7× 101 0.8× 78 1.1× 120 2.6× 63 1.5× 13 340
Carol Barch United States 9 251 1.9× 109 0.9× 29 0.4× 46 1.0× 195 4.8× 14 387
Mikael S. Mouradian Canada 10 170 1.3× 52 0.4× 142 2.0× 117 2.5× 40 1.0× 15 325

Countries citing papers authored by J Spiesser

Since Specialization
Citations

This map shows the geographic impact of J Spiesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Spiesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Spiesser more than expected).

Fields of papers citing papers by J Spiesser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Spiesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Spiesser. The network helps show where J Spiesser may publish in the future.

Co-authorship network of co-authors of J Spiesser

This figure shows the co-authorship network connecting the top 25 collaborators of J Spiesser. A scholar is included among the top collaborators of J Spiesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Spiesser. J Spiesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Berg, Jenny, et al.. (2007). Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: A European model based on the CLARITY and COMMIT trials. Clinical Therapeutics. 29(6). 1184–1202. 17 indexed citations
2.
Hankey, Graeme J., et al.. (2007). Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology. 68(19). 1583–1587. 133 indexed citations
3.
Hankey, Graeme J., J Spiesser, Zalmaï Hakimi, Patrizia Carità, & Sylvie Gabriel. (2007). Time frame and predictors of recovery from disability following recurrent ischemic stroke. Neurology. 68(3). 202–205. 45 indexed citations
4.
Weintraub, William S., Elizabeth M. Mahoney, Shamir R. Mehta, et al.. (2004). 1137-77 Long-term cost-effectiveness of clopidogrel in patients having percutaneous coronary intervention early after acute coronary syndrome: Results from PCI-CURE. Journal of the American College of Cardiology. 43(5). A296–A296. 3 indexed citations
5.
Palmer, Andrew, William J. Valentine, Stéphane Roze, et al.. (2004). Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries. Current Medical Research and Opinion. 21(1). 19–26. 44 indexed citations
6.
7.
8.
9.
Nagy, J., et al.. (2003). PCV31 ECONOMIC EVALUATION OF CLOPIDOGREL IN SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN HUNGARY. Value in Health. 6(6). 654–654. 1 indexed citations
10.
11.
12.
13.
Lévy, E, et al.. (2000). PMH5: IMPACT OF AMISULPRIDE ON HEALTH CARE RESOURCES IN SCHIZOPHRENIA: PRELIMINARY RESULTS OF A FRENCH STUDY. Value in Health. 3(5). 345–345. 1 indexed citations
14.
Allain, Pierre Etienne, et al.. (1978). [Study of blood levels of a number of metals (Al, Mn, Cd, Pb, Cu, Zn) in chronic haemodialysis patients before and after dialysis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(2). 92–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by César Minelli Breakdown of academic impact, for papers by David Leander Rimmele Breakdown of academic impact, for papers by Sven‐Erik Eriksson Breakdown of academic impact, for papers by Kürşad Kutluk Breakdown of academic impact, for papers by A. Doris Baumgartner Breakdown of academic impact, for papers by Lai‐Kin Wong Breakdown of academic impact, for papers by David S Liebeskind Breakdown of academic impact, for papers by Lucie Garnier Breakdown of academic impact, for papers by Carol Barch Breakdown of academic impact, for papers by Mikael S. Mouradian
Rankless by CCL
2026